Genoray Co. Ltd (122310) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.78 Billion ≈ $3.24 Million USD) by net assets (₩83.75 Billion ≈ $56.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genoray Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.

Genoray Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency. Explore Genoray Co. Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Porn Prom Metal Public Company Limited BK:PPM	0.008x
Bayu Buana Tbk JK:BAYU	-0.131x
Texchem Resources Bhd KLSE:8702	0.153x
Xiabuxiabu Catering Management (China) Holdings Co. Ltd F:0XI	0.589x
Ascent Solar Technologies, Inc. NASDAQ:ASTI	-0.065x
SunCar Technology Group Inc. NASDAQ:SDA	0.185x
FORCS Co.Ltd KQ:189690	0.034x
Crown Crafts Inc NASDAQ:CRWS	0.137x

Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2025. View current stock price of Genoray Co. Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩83.75 Billion ≈ $56.76 Million	₩5.26 Billion ≈ $3.56 Million	0.063x	-59.38%
2024-12-31	₩85.89 Billion ≈ $58.21 Million	₩13.27 Billion ≈ $9.00 Million	0.155x	+315.37%
2023-12-31	₩95.53 Billion ≈ $64.74 Million	₩3.55 Billion ≈ $2.41 Million	0.037x	-77.94%
2022-12-31	₩87.96 Billion ≈ $59.61 Million	₩14.84 Billion ≈ $10.05 Million	0.169x	-13.58%
2021-12-31	₩78.82 Billion ≈ $53.41 Million	₩15.38 Billion ≈ $10.43 Million	0.195x	+52.63%
2020-12-31	₩66.53 Billion ≈ $45.08 Million	₩8.51 Billion ≈ $5.77 Million	0.128x	-28.49%
2019-12-31	₩59.59 Billion ≈ $40.38 Million	₩10.65 Billion ≈ $7.22 Million	0.179x	+16.67%
2018-12-31	₩44.97 Billion ≈ $30.48 Million	₩6.89 Billion ≈ $4.67 Million	0.153x	-16.72%
2017-12-31	₩24.30 Billion ≈ $16.47 Million	₩4.47 Billion ≈ $3.03 Million	0.184x	-21.57%
2016-12-31	₩14.80 Billion ≈ $10.03 Million	₩3.47 Billion ≈ $2.35 Million	0.235x	+26.88%
2015-12-31	₩11.35 Billion ≈ $7.69 Million	₩2.10 Billion ≈ $1.42 Million	0.185x	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$27.62 Million

₩40.75 Billion KRW

Market Cap Rank

#24152 Global

#1701 in Korea

Share Price

₩3355.00

Change (1 day)

-0.15%

52-Week Range

₩3200.00 - ₩5290.00

All Time High

₩11740.92